| Names | |
|---|---|
|
IUPAC name
N-[3-Chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide
|
|
| Other names
Rafoxanid, raphoxanide
|
|
| Identifiers | |
|
3D model (Jmol)
|
|
| ChemSpider | |
| ECHA InfoCard | 100.041.029 |
| EC Number | 245-148-9 |
| KEGG | |
| MeSH | D011888 |
|
PubChem CID
|
|
| UNII | |
|
|
|
|
| Properties | |
| C19H11Cl2I2NO3 | |
| Molar mass | 626.01 g/mol |
| Appearance | Slight yellowish-brown injectable solution and white oral solution |
| In oily solutes | |
| Pharmacology | |
| QP52AG05 (WHO) | |
| Hazards | |
| Main hazards | Has low safety index (6 times as normal dose) |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
Rafoxanide is a salicylanilide used as an anthelmintic.